ANTWERP and AALST,Belgium,Oct. 29,2024-- Bluecrux,a leading value chain consulting and technology firm,is thrilled to announce its successful collaboration with Bridgestone on the implementation of SA
10-29
-- Head-to-head clinical results indicate a potential best-in-class combined efficacy & safety profile of non-adjuvanted bivalent RSV vaccine candidate (SCB-1019) --
10-29
SINGAPORE,Oct. 29,2024-- Following the tremendous success of its inaugural edition,NRF 2025: Retail\'s Big Show Asia Pacific is set to return with double capacity for more than 10,000 delegates. Orga
10-29
SINGAPORE,Oct. 28,2024-- Digital travel platform Agoda reveals the top searched cities in India for Diwali celebrations,and it\'s New Delhi that comes out on top among international visitors. Goa tak
10-28
GUANGZHOU,China,Oct. 28,2024--Recently,the National Bureau of Statistics of China announced that investment in high-tech industries continued to scale up in the first three quarters,of which the inve
10-28
SINGAPORE,Oct. 25,2024-- The Alpha Trading Cup (ATC) 2024,a premier live trading competition that brought together over 1,149 traders from 22 countries across the globe,culminated in an exclusive awa
10-26
BEIJING,Oct. 25,2024--Chindata Group officially unveiled its latest innovation,the AI Data Center Total Solution 2.0,at the 2024 China Computing Power Conference. Designed to meet the growing demands
10-26
BEIJING,Oct. 24,2024-- As a representative of new quality productive forces,the low-altitude economy has become an important direction to foster new drivers.
10-25
Pierre Fabre Laboratories Announce First Patient Dosed in Phase I/II Clinical Trial of PFL-002/VERT-002,an Innovative Targeted Therapy Intended to Treat Non-Small Cell Lung Cancer with MET Alterations
10-25
SINGAPORE,Oct. 24,2024-- Singapore-basedTower Capital Asia ("TCA" or "the Firm") is pleased to announce that Ectivate Pte Ltd ("Ectivate"),an investment platform owned by
10-25
The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange
Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference
Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement
MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM
©copyright 2009-2020 Singapore Info Map
